Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis - Wikidata - awgldk - TriplyDB

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

http://www.wikidata.org/entity/Q36393788

about

Circulation and chemotaxis of fetal hematopoietic stem cells Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases Concise review: bone marrow autotransplants for liver disease?Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6.Hematopoietic progenitors from early murine fetal liver possess hepatic differentiation potential Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 mice.Relationships between hematopoiesis and hepatogenesis in the midtrimester fetal liver characterized by dynamic transcriptomic and proteomic profiles The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny.Hepatocyte nuclear factor-4alpha induces transdifferentiation of hematopoietic cells into hepatocytes Dynamic partnership between TFIIH, PGC-1α and SIRT1 is impaired in trichothiodystrophy.Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor Activation of stem cells in hepatic diseases.Sequential morphological characteristics of murine fetal liver hematopoietic microenvironment in Swiss Webster mice.EpCAM and the biology of hepatic stem/progenitor cells Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats Hepatocyte progenitors in man and in rodents--multiple pathways, multiple candidates.Bioreactors for extracorporeal liver support.Glucocorticoids accelerate maturation of the heme pathway in fetal liver through effects on transcription and DNA methylation Multilayer nanofilms as substrates for hepatocellular applications.Bioartificial liver systems: why, what, whither?Cell sources for in vitro human liver cell culture models.Evaluation of the long-term reconstituting subset of hematopoietic stem cells with CD150 Unbalanced distribution of materials: the art of giving rise to hepatocytes from liver stem/progenitor cells.Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.Liver stem/progenitor cells: their characteristics and regulatory mechanisms.Extramedullary hematopoiesis (EMH) in laboratory animals: offering an insight into stem cell research.Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.Strategies to produce hepatocytes and hepatocyte-like cells from pluripotent stem cells.Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.Effect of oncostatin M on uridine diphosphate-5'-glucuronosyltransferase 1A1 through cross talk with constitutive androstane receptor.Derivation, characterization, and phenotypic variation of hepatic progenitor cell lines isolated from adult rats.Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.The basic helix-loop-helix transcription factor, Mist1, induces maturation of mouse fetal hepatoblasts.Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor.Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue.Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice.Hepatic acute phase response protects the brain from focal inflammation during postnatal window of susceptibility.Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

P2860

Q24800273-C347664F-35F4-4B5F-937C-ACB9AC4924A7 Q26743361-B1A84D16-BBD5-4404-AB97-4DF380A62BD0 Q26749647-B47DD625-DA8C-4311-B639-1C05DD669081 Q27010009-EC357AF7-83FC-4014-807E-DD2025BBD37A Q27336171-82E6C38A-310A-4AFB-859B-4809EC70D35C Q28586222-DBB1D752-4257-45E5-B235-970888E55481 Q31123389-AC841F22-C035-4C8E-995B-A3467B431A41 Q33513479-72D287E7-DDAC-45E0-8B14-C9C7E2AAD91D Q33599402-0935A223-90F4-4BB9-B027-900FEDA1819E Q33717575-D323DE0D-7479-463A-883A-5DFE9D9FB144 Q34394923-EF4B433C-0B77-4796-9AFE-6648FC9ACA7A Q34398986-3489288A-E9E8-428C-AC6B-462F6D4A676D Q34554113-A7414D02-959C-4812-B7DA-03C9D96C8DE3 Q35009784-246EBB9A-0BF2-4C2E-8F86-5CB39B8AE6A9 Q35086401-D90612C7-8F0C-4226-B767-117DA4B0B23E Q35666104-63071EEA-FE01-41DD-85D2-E454C868CE62 Q35963215-E91CFDB2-5C5D-4CBD-8872-823A916B139C Q36022174-2389D84F-2E48-4A14-BF2C-412A9D445F1D Q36530003-2644956C-DDEE-4B2D-98E4-63E111AF39E9 Q36838877-F5DF96EC-177E-443F-A9E8-64E9B91264AA Q37087406-09E4988C-5BFE-4D21-B836-916635FE7C1D Q37202810-A02FD1B0-C3B3-47A6-AA28-F32C8BD8EFF3 Q37208518-051A7385-6EE3-40D2-9318-9549D565BD4E Q37439297-5E477EF1-ED30-49D7-8546-109E94FDA15D Q37562312-A4F070F7-3B4C-499F-8E6C-8A87E9DC42AE Q37756278-52F4148F-BF00-4653-AB9F-CF29DD12453B Q37827017-9E5907E3-7FC1-4525-825F-F5352B8347EE Q38342415-90C7E46B-60FD-416F-9326-BC18D6D59D39 Q38910479-B9923F66-0179-40F1-9F91-FF69B2387614 Q39698876-BFF5184D-CC56-4B31-A44D-A211930E75A0 Q39866444-1CB38D2E-EAFA-4667-A246-C5CFC100F3CA Q39969799-AAEF5551-DC91-4848-9B5A-BA013B8E543F Q40752921-5B95B94D-45C1-47A8-916B-237EF58D84AE Q40759121-BA388A21-FE3E-4521-AB67-02B74386333E Q42151549-2D0EC0C8-C7E3-4D4E-B72D-38E0DE8EA3B8 Q43096306-C082AB63-1061-4A23-8979-4C691550F3BC Q45732610-177E9645-77DD-4873-B532-25A5941DCD49 Q46436507-A06B85EC-7734-4F66-ADBD-FC58D59DCC69 Q47848259-A39453DA-9687-4B1D-87FB-DCE2F5FB44F2 Q53155879-84114ACC-4DAB-4ED0-A899-4D6A943996C3

P2860

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

http://www.wikidata.org/entity/Q36393788

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@ast

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@en

type

label

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@ast

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@en

prefLabel

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@ast

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@en

P1433

Q36393788-26B8E6D8-F0D2-407F-843F-0DA92CFA00DC

P1476

Q36393788-2D48C5C6-0B34-46F1-81E1-3688F6AFA4A5

P2093

Q36393788-09C84232-70C6-4819-A1DD-6545A461FA6C

Q36393788-26A9DA4B-87CC-4188-AC13-EEA4F008D0F9

Q36393788-30CC39DB-9FD3-41C3-94F9-982809EC3F27

Q36393788-74474C60-D602-4F82-AAC0-D56E7CED6B6F

Q36393788-ACF5AAF7-809C-42F6-AA00-51A4483FF6CC

Q36393788-B4A96DB8-DEAC-4ABC-9110-CD65310E1807

Q36393788-BC9F522E-FE2A-4F03-B1C0-C097F17A413E

Q36393788-E354C667-1E6B-4908-A0D8-A8BF364DF166

P2860

Q36393788-04D1752A-F9F3-4E28-8CD5-F7C9FD7BF02B

Q36393788-165A2794-A5A8-4EF1-93F2-9E009C3DAFE2

Q36393788-28D3CD0C-AACE-45EC-A83A-3155B06352F9

Q36393788-2BF40695-3003-495D-9397-80E1F0D5458B

Q36393788-3A0FEB50-3979-44F7-9C0A-DC6137CA1207

Q36393788-65789859-86DF-4CA6-B280-069BB6824DD8

Q36393788-740FBBDD-EE2E-4431-BDA9-90295D257E15

Q36393788-74FB051A-B1A9-440C-998E-F38D47888A68

Q36393788-8C1A4EF2-A241-494C-BA07-ED6C2878EF4B

Q36393788-90130C45-A9A7-45EC-853E-C92C35888CAD

P304

Q36393788-716005B5-D9A0-45D8-9C2C-F5414409E63B

P31

Q36393788-F5F92446-210A-4AF4-8C3C-137D7566E995

P356

Q36393788-F79C7ACA-0BDF-4E9C-B4D0-FA1ACB5D2FCB

P407

Q36393788-5D627BD0-39D9-4E9F-A390-CB2DA18AD74E

P433

Q36393788-C3140B65-B059-4434-A680-895E448DC363

P478

Q36393788-77941A59-E4B0-4028-8231-446138C2F689

P577

Q36393788-A17E005C-9C58-49B6-AAF5-1256FB1556FD

P5875

Q36393788-E3182F74-D9BB-4E64-AE61-793A7E7D05DF

P698

Q36393788-E682D72F-095F-4FD1-82F8-E67E7FEE0DF1

P921

Q36393788-61A4B183-A6EF-4349-AB17-8EA90E2A5E92

P932

Q36393788-86C6083A-68D2-4331-9112-6C498234349D

P356

PNAS.96.13.7265

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis

@en

P2093

Ito Y

http://www.w3.org/2001/XMLSchema#string

Kamiya A

http://www.w3.org/2001/XMLSchema#string

Kinoshita T

http://www.w3.org/2001/XMLSchema#string

Miyajima A

http://www.w3.org/2001/XMLSchema#string

Nakahata T

http://www.w3.org/2001/XMLSchema#string

Sekiguchi T

http://www.w3.org/2001/XMLSchema#string

Tsuji K

http://www.w3.org/2001/XMLSchema#string

Xu MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a specific receptor for mouse oncostatin M

Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit

Gp130 and the interleukin-6 family of cytokines

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders

Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac

Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties

P304

7265-7270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.13.7265

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24452996

http://www.w3.org/2001/XMLSchema#string

P698

10377403

http://www.w3.org/2001/XMLSchema#string

P921

P932

22074

http://www.w3.org/2001/XMLSchema#string